Global Dermal Filler and Botolinum Toxin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dermal Filler and Botolinum Toxin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
This report studies the dermal filler and botolinum toxin market. Dermal filler and botolinum toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.
Global Dermal Filler and Botolinum Toxin market is projected to reach US$ 30390 million in 2029, increasing from US$ 12050 million in 2022, with the CAGR of 13.9% during the period of 2024 to 2029. Demand from Aesthetic Restoration and Wrinkle Reduction are the major drivers for the industry.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dermal Filler and Botolinum Toxin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
Segment by Type
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Aesthetic Restoration
Wrinkle Reduction
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Dermal Filler and Botolinum Toxin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dermal Filler and Botolinum Toxin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dermal Filler and Botolinum Toxin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dermal Filler and Botolinum Toxin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dermal Filler and Botolinum Toxin introduction, etc. Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dermal Filler and Botolinum Toxin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Global Dermal Filler and Botolinum Toxin market is projected to reach US$ 30390 million in 2029, increasing from US$ 12050 million in 2022, with the CAGR of 13.9% during the period of 2024 to 2029. Demand from Aesthetic Restoration and Wrinkle Reduction are the major drivers for the industry.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dermal Filler and Botolinum Toxin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
Segment by Type
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Segment by Application
Aesthetic Restoration
Wrinkle Reduction
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Dermal Filler and Botolinum Toxin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dermal Filler and Botolinum Toxin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dermal Filler and Botolinum Toxin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dermal Filler and Botolinum Toxin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dermal Filler and Botolinum Toxin introduction, etc. Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dermal Filler and Botolinum Toxin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices